Article

Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in…

Cancer Management and Research · 2019 · Auezova R, Ivanova N, Akshulakov S, Zhetpisbaev B, Kozhakhmetova A, Ryskeldiyev N, Mustafin K, Teltayev D, Auezova L

Key facts

Title Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
First author Auezova R, Ivanova N, Akshulakov S, Zhetpisbaev B, Kozhakhmetova A, Ryskeldiyev N, Mustafin K, Teltayev D, Auezova L
Journal Cancer Management and Research
Published Apr 15, 2019
DOI 10.2147/CMAR.S195754
Devices mentioned K030899, K895204, K991372
Product codes mentioned BSO, DCN, CFJ, CZW, DCK, JJY, JIS, JIX, NQD

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature